Sign Up to like & get
recommendations!
1
Published in 2022 at "Analytical chemistry"
DOI: 10.1021/acs.analchem.2c01602
Abstract: Amyloid-β oligomer (AβO) is widely regarded as a reliable biomarker for the early diagnosis of Alzheimer's disease (AD). In this study, a signal on-off ratiometric electrochemical immunosensor has been developed for ultrasensitive detection of AβO.…
read more here.
Keywords:
ratiometric electrochemical;
nanoparticle engineered;
amyloid oligomer;
detection ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Acta Neuropathologica Communications"
DOI: 10.1186/s40478-017-0429-5
Abstract: Cerebral amyloid angiopathy (CAA) induces various forms of cerebral infarcts and hemorrhages from vascular amyloid-β accumulation, resulting in acceleration of cognitive impairment, which is currently untreatable. Soluble amyloid-β protein likely impairs cerebrovascular integrity as well…
read more here.
Keywords:
memory;
amyloid;
caa;
taxifolin ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Alzheimer's Disease"
DOI: 10.3233/jad-179941
Abstract: The amyloid-β oligomer (AβO) hypothesis was introduced in 1998. It proposed that the brain damage leading to Alzheimer’s disease (AD) was instigated by soluble, ligand-like AβOs. This hypothesis was based on the discovery that fibril-free…
read more here.
Keywords:
beginning third;
hypothesis beginning;
third decade;
hypothesis ... See more keywords